Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What Future CAGR is Anticipated for the Breast Cancer Diagnostics Market Over the 2025–2034 Period?

The market size for breast cancer diagnostics has seen significant growth in the recent past. The projection is that it will surge from $4.68 billion in 2024 to $5.04 billion in 2025, with a compound annual growth rate (CAGR) of 7.9%. Factors such as awareness campaigns, mammography screening, technological progress, genetic testing, and a multidisciplinary approach have all contributed to this growth during the historic period.

The market size for breast cancer diagnostics is anticipated to experience substantial growth in the coming years, reaching $6.91 billion in 2029 with a compound annual growth rate (CAGR) of 8.2%. This projected increase during the forecast period can be linked to factors such as personalized medicine, liquid biopsies, 3D mammography (tomosynthesis), AI and machine learning, as well as telemedicine and remote consultations. Moreover, the forecast period will witness prominent trends such as advancements in imaging technologies, the rise of personalized medicine, the use of liquid biopsies, the application of AI and machine learning.

How Are the key drivers expanding the growth of the Breast Cancer Diagnostics Market?

The surge in the occurrence of breast cancer necessitates an increase in diagnostic equipment, thereby escalating the demand in the breast cancer diagnostics market. With breast cancer being the most prevalent type of cancer, affecting 2.1 million women annually and accounting for the highest number of cancer-related deaths in women, the emphasis has shifted towards early diagnosis. The aim is to detect a higher percentage of breast cancers in their initial stages to provide more effective treatment and lower the mortality rate. For instance, the American Cancer Society, a US-based health organization committed to the eradication of cancer, reported in January 2022, an estimated 287,850 new cases of invasive breast cancer, along with 51,400 cases of DCIS. In addition to this, an expected 43,250 breast cancer fatalities are predicted in the United States for the year 2022. Consequently, the escalating incidence of breast cancer is anticipated to propel the growth of the breast cancer diagnostics market.

Get Your Free Sample of the Global Breast Cancer Diagnostics Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=3284&type=smp

Who Are the Influential Players Fueling Innovation and Growth in the Breast Cancer Diagnostics Market?

Major companies operating in the breast cancer diagnostics market include Abbott Laboratories, Myriad Genetics Inc., Hologic Inc., Koninklijke Philips N.V., Fujifilm Holdings Corporation, GE Healthcare, Thermo Fisher Scientific Inc., Siemens AG, NanoString Technologies Inc., Gamma Medica Inc., Aurora Imaging Technology Inc., Dilon Technologies Inc., Exact Sciences Corporation, F. Hoffmann-La Roche Ltd, Micrima Limited, Provista Diagnostics Inc., Leica Biosystems Nussloch GmbH, bioTheranostics Inc., Bio-Rad Laboratories Inc., Illumina Inc., Biocept Inc., Epigenomics AG, AstraZeneca plc, Quest Diagnostics Incorporated, Agilent Technologies Inc., Cepheid, Guardant Health Inc., Invitae Corporation, Natera Inc., NeoGenomics Laboratories Inc., Oncocyte Corporation, PerkinElmer Inc., Sysmex Corporation, Veracyte Inc.

What Impact Are Industry Trends Having on the Breast Cancer Diagnostics Market’s Future Prospects?

The progression of technology is a significant trend in the market for breast cancer diagnostics. Numerous innovative methods, suitable for diagnosing and treating breast cancer, have been developed recently. 3D mammography, or breast tomosynthesis, is able to create a 3-D model of the breast by photographing it from various angles. Niramai, an Indian Health-Tech firm, unveiled a cutting-edge solution known as Thermalytix in September 2022. This is an automatic screening and diagnostic instrument for breast cancer, merging thermal imaging and AI.

Get Instant Access to the Global Breast Cancer Diagnostics Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/breast-cancer-diagnostics-global-market-report

How Are Key Segments Defining the Competitive Landscape of the Breast Cancer Diagnostics Market?

The breast cancer diagnostics market covered in this report is segmented –

1) By Type: Imaging, Biopsy, Genomic Tests, Blood Tests, Other Types

2) By Technology: Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Immunohistochemical (IHC), Other Technologies

3) By Cancer Type: BRCA Breast Cancer, ER And PR Breast Cancer, HER 2 Breast Cancer, EGFR Mutation Test Breast Cancer, Other Cancer Types

4) By Diagnostic Type: Ionizing Breast Imaging Technologies, Non-ionizing Imaging Technologies

5) By End Users: Hospitals And Clinics, Cancer Research Centers, Diagnostic Laboratories, Ambulatory Surgical Centers

Subsegments:

1) By Imaging: Mammography, Ultrasound Imaging, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Tomosynthesis

2) By Biopsy: Needle Biopsy, Core Needle Biopsy, Fine Needle Aspiration Biopsy (FNA), Stereotactic Biopsy

3) By Genomic Tests: Oncotype DX, MammaPrint, PAM50, BRCA1 Or 2 Testing

4) By Blood Tests: Liquid Biopsy, Circulating Tumor DNA (ctDNA) Tests, Circulating Tumor Cells (CTCs) Tests

5) By Other Types: Hormone Receptor Tests, HER2 Tests, Genetic Mutation Testing

What Regions Are Leading the Growth Trajectory of the Breast Cancer Diagnostics Market?

North America was the largest region in the breast cancer diagnostics market in 2023. Asia-Pacific was the second largest region in the breast cancer diagnostics industry. The regions covered in the breast cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Key Characteristics That Define the Breast Cancer Diagnostics Market?

Breast cancer diagnostics refer to the various methods, tests, and procedures used to detect and diagnose breast cancer in individuals. These diagnostics help identify the presence of cancer cells in breast tissue, determine the stage of cancer, and guide treatment decisions.

Browse Through More Similar Reports By The Business Research Company:

Breast Cancer Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/breast-cancer-drugs-global-market-report

Oncology Biosimilars Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/oncology-biosimilar-global-market-report

Cancer Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: